• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Renalytix Ai Plc ADR (NQ: RNLX )

    0.2071 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Renalytix Ai Plc ADR

    < Previous 1 2 3 4 5 6 7 8 Next >
    Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
    From Renalytix plc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Renalytix to Present at Stifel Healthcare Conference
    From Renalytix plc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers 
    Via Benzinga
    Recap: Renalytix Q4 Earnings
    Renalytix (NASDAQ:RNLX) reported its Q4 earnings results on Monday, October 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Recap: Renalytix Q3 Earnings
    Renalytix (NASDAQ:RNLX) reported its Q3 earnings results on Thursday, June 30, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
    Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product... 
    Via Benzinga
    Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session
    Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers PLx Pharma (NASDAQ:PLXP) stock increased by 15.5% to $0.7 during Monday's pre-market session. The market value of their outstanding shares is at $20.3 million. 
    Via Benzinga
    Renalytix Reports Full Year Fiscal 2022 Results
    From Renalytix plc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers 
    Via Benzinga
    MarketBeat Podcast, 3 Small Caps With Big Upside
    Today on The MarketBeat Podcast is Randy Baron, portfolio manager at Pinnacle Associates. Three stocks Randy discusses today have small market capitalizations. 
    Via MarketBeat
    Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
    Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
    Via Benzinga
    Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31
    From Renalytix plc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million. 
    Via Benzinga
    KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology
    Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system underscore value of KidneyIntelX™ platform in improving cost... 
    From Renalytix plc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers 
    Via Benzinga
    121 Stocks That Hit Their 52-Week Low
    New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      On Wednesday, 297 companies achieved new lows for the year. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 250 stocks hit new 52-week lows. 
    Via Benzinga
    Netflix To $210? Here's The Biggest Price Target Changes For Friday
    Piper Sandler cut The Goldman Sachs Group, Inc. (NYSE: GS) price target from $430 to $410. Goldman Sachs shares fell 0.1% to $296.79 in pre-market trading. 
    Via Benzinga
    Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
    Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase... 
    Via Benzinga
    Stocks Eye Dismal Close to Q2, First Half of 2022
    The S&P 500 is set to notch its worst first half of the year since 1962, while the Dow and Nasdaq aren't faring much better as they stare at steep losses of their own. 
    Via Talk Markets
    Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
    Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Earnings Scheduled For June 30, 2022
    Companies Reporting Before The Bell • Tsakos Energy Navigation (NYSE:TNP) is expected to report quarterly loss at $0.21 per share on revenue of $152.71 million. 
    Via Benzinga
    Renalytix AI's Earnings: A Preview
    Renalytix AI (NASDAQ:RNLX) is set to give its latest quarterly earnings report on Thursday, 2022-06-30. Here's what investors need to know before the announcement. Analysts estimate that Renalytix AI... 
    Via Benzinga
    3 Penny Stocks That Wall Street Thinks Are Undervalued
    By and large penny stocks deservedly have a bad rap, but right now selective attention to what Wall Street has to say makes sense for buyers. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers 
    Via Benzinga
    70 Biggest Movers From Friday
    Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.